Orpanoxin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameOrpanoxin
Drug Alias NameF-776
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A